Veterinary Medicines

Nobivac Tricat Trio, Lyophilisate and Solvent for Suspension for Injection for Cats

Authorised
  • Feline panleucopenia virus, strain MW-1, Live
  • Feline rhinotracheitis virus, strain G2620A, Live
  • Feline calicivirus, strain F9, Live
Download as PDF

Product identification

Medicine name:
Nobivac Tricat Trio liofilizat in vehikel za suspenzijo za injiciranje za mačke
Nobivac Tricat Trio, Lyophilisate and Solvent for Suspension for Injection for Cats
Active substance:
  • Feline panleucopenia virus, strain MW-1, Live
  • Feline rhinotracheitis virus, strain G2620A, Live
  • Feline calicivirus, strain F9, Live
Target species:
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Feline panleucopenia virus, strain MW-1, Live
    0.63
    tissue culture infective dose 50
    /
    1.00
    Dose
  • Feline rhinotracheitis virus, strain G2620A, Live
    0.72
    plaque forming unit
    /
    1.00
    Dose
  • Feline calicivirus, strain F9, Live
    0.66
    plaque forming unit
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AD04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovenia
Package description:
  • Available only in Slovenian
  • Available only in Slovenian
  • Available only in Slovenian
  • Available only in Slovenian
  • (ID5) 5 Dose; 5 millilitre(s): Box (plastic) with 5 Box (plastic) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
  • (ID6) 10 millilitre(s); 10 Dose: Box (plastic) with 10 Box (plastic) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
  • (ID7) 25 millilitre(s); 25 Dose: Box (plastic) with 25 Box (plastic) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
  • (ID8) 50 Dose; 50 millilitre(s): Box (plastic) with 50 Box (plastic) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
  • MR/V/0237/001
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0240/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/03/2023
Download
Slovenian (PDF)
Published on: 26/05/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 13/12/2022
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 26/05/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."